Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions

By Ruiz J.C.   Campistol J.M.   Mota A.   Prats D.   Gutierrez J.A.   Castro A.   Garcia J.   Morales J.M.   Grynio J.M.   Gomez J.M.   Arias M.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1669-1670

Elsevier

Access to resources Recommend Favorite

Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients

By Blume C.   Hollenbeck M.   Ivens K.   Heering P.   Hetzel G.R.   Grabensee B.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3161-3163

Elsevier

Access to resources Recommend Favorite

Concerns regarding the current paradigm for chronic allograft rejections

By Orosz C.G.   Sedmak D.D.  

Transplant Immunology, Vol. 5, Iss. 3, 1997-09 ,pp. : 169-172

Elsevier

Access to resources Recommend Favorite

Acute allograft rejection following conversion to a new cyclosporine formulation in pediatric renal transplant patients

By Crocker J.   Renton K.   Wade A.   McLellan H.   Acott P.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2002-2005

Elsevier

Access to resources Recommend Favorite

Separate Risk Factors for the Development of Transplant Glomerulopathy vs Chronic Tubulointerstitial Rejection

By Kupin W.   Nakhleh R.   Lee M.   Venkat K.K.   Goggins M.   Mozes M.   Escobar F.   Abouljoud M.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 245-246

Elsevier

Access to resources Recommend Favorite